<unk>  is a sodium glucose co-transporter 2 (SGLT2) inhibitor that is FDA approved for the adjunct of diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.   Common adverse reactions include female genital mycotic infections.
Ertugliflozin
Linagliptin
Liraglutide
Exenatide
Vildagliptin
Saxagliptin
Sitagliptin
Mitiglinide